[go: up one dir, main page]

EE04296B1 - Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini - Google Patents

Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Info

Publication number
EE04296B1
EE04296B1 EEP200100014A EEP200100014A EE04296B1 EE 04296 B1 EE04296 B1 EE 04296B1 EE P200100014 A EEP200100014 A EE P200100014A EE P200100014 A EEP200100014 A EE P200100014A EE 04296 B1 EE04296 B1 EE 04296B1
Authority
EE
Estonia
Prior art keywords
sertraline
agent containing
antidepressant agent
containing pramipexole
pramipexole
Prior art date
Application number
EEP200100014A
Other languages
English (en)
Estonian (et)
Inventor
Maj Jerzy
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100014A publication Critical patent/EE200100014A/xx
Publication of EE04296B1 publication Critical patent/EE04296B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100014A 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini EE04296B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (2)

Publication Number Publication Date
EE200100014A EE200100014A (et) 2002-06-17
EE04296B1 true EE04296B1 (et) 2004-06-15

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100014A EE04296B1 (et) 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Country Status (32)

Country Link
US (1) US6255329B1 (pt)
EP (1) EP1093369B1 (pt)
JP (1) JP2002520273A (pt)
KR (1) KR100557692B1 (pt)
CN (1) CN1230168C (pt)
AR (1) AR019896A1 (pt)
AT (1) ATE228365T1 (pt)
AU (1) AU762128B2 (pt)
BG (1) BG64972B1 (pt)
BR (1) BR9911768A (pt)
CA (1) CA2336833C (pt)
CZ (1) CZ294087B6 (pt)
DE (2) DE19830201A1 (pt)
DK (1) DK1093369T3 (pt)
EA (1) EA003142B1 (pt)
EE (1) EE04296B1 (pt)
ES (1) ES2183583T3 (pt)
HU (1) HUP0103922A3 (pt)
ID (1) ID27776A (pt)
IL (1) IL140603A0 (pt)
MY (1) MY117969A (pt)
NO (1) NO20010064L (pt)
NZ (1) NZ509729A (pt)
PL (1) PL195043B1 (pt)
PT (1) PT1093369E (pt)
RS (1) RS49795B (pt)
SK (1) SK284923B6 (pt)
TR (1) TR200100146T2 (pt)
TW (1) TW592698B (pt)
WO (1) WO2000002542A2 (pt)
YU (1) YU401A (pt)
ZA (1) ZA200100090B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
EP2305252A1 (en) * 2001-12-11 2011-04-06 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション Ｒ（＋）プラミペキソールを用いた神経回復
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
CA2760527A1 (en) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
EP3038467B1 (en) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
ES2246058T3 (es) * 1996-03-29 2006-02-01 Pfizer Inc. Derivados bencil(iden)-lactama, su preparacion y su uso como (ant)agonistas selectivos de receptores 5-ht1a y/o 5-ht1d.
CA2273809A1 (en) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating movement disorders
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
AR019896A1 (es) 2002-03-20
CA2336833C (en) 2008-09-23
ATE228365T1 (de) 2002-12-15
KR100557692B1 (ko) 2006-03-07
EE200100014A (et) 2002-06-17
BG105112A (bg) 2001-10-31
CN1308533A (zh) 2001-08-15
EA200100084A1 (ru) 2001-08-27
ZA200100090B (en) 2002-04-04
WO2000002542A2 (de) 2000-01-20
EA003142B1 (ru) 2003-02-27
CA2336833A1 (en) 2000-01-20
CZ200177A3 (en) 2001-06-13
DK1093369T3 (da) 2002-12-16
US6255329B1 (en) 2001-07-03
DE59903556D1 (de) 2003-01-09
AU5030399A (en) 2000-02-01
KR20010079491A (ko) 2001-08-22
EP1093369A2 (de) 2001-04-25
BR9911768A (pt) 2001-04-03
SK112001A3 (en) 2001-10-08
YU401A (sh) 2003-10-31
TR200100146T2 (tr) 2001-07-23
JP2002520273A (ja) 2002-07-09
WO2000002542A3 (de) 2000-06-22
NZ509729A (en) 2003-06-30
NO20010064L (no) 2001-03-02
HK1037976A1 (en) 2002-03-01
TW592698B (en) 2004-06-21
CN1230168C (zh) 2005-12-07
ES2183583T3 (es) 2003-03-16
SK284923B6 (sk) 2006-02-02
DE19830201A1 (de) 2000-01-13
HUP0103922A3 (en) 2002-08-28
RS49795B (sr) 2008-06-05
NO20010064D0 (no) 2001-01-05
IL140603A0 (en) 2002-02-10
AU762128B2 (en) 2003-06-19
MY117969A (en) 2004-08-30
EP1093369B1 (de) 2002-11-27
PL345842A1 (en) 2002-01-14
PT1093369E (pt) 2003-03-31
CZ294087B6 (cs) 2004-10-13
PL195043B1 (pl) 2007-08-31
HUP0103922A2 (hu) 2002-03-28
BG64972B1 (bg) 2006-11-30
ID27776A (id) 2001-04-26

Similar Documents

Publication Publication Date Title
EE04296B1 (et) Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
EE200000766A (et) Ravimkoostis, mis sisaldab COX-2 inhibiitorit ja iNOS inhibiitorit
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
DE69732778D1 (de) Weiche nitrilkautchuk-zusammensetzung
NO20005503L (no) Ny anvendelse
DE69929047D1 (de) Haarbehandlungsmittel
DE69919970D1 (de) Axiallüfter
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
DE69822124D1 (de) Axiallüfter
DE59906199D1 (de) Elastischer bremsenkörper
BR9900685B1 (pt) composição sólida desodorante e utilização cosmética de uma composição sólida.
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
DK1112003T3 (da) Ny sammensætning og anvendelse
EP1163852A4 (en) Masking agent
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
EE04087B1 (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
NO20005483L (no) Ny sammensetning
ID26780A (id) Senyawa-senyawa tienopiridina, hasil dan kegunaannya
IL162014A0 (en) Shape-recovering material suitable for application of an attachment, and its use
SI1093369T1 (sl) Sredstvo z antidepresivnim učinkom, ki obsega pramipeksol in sertralin

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090702